Clinical Trials
4 trialsNCT05099172 2026-05-13
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
Bayer
Phase 1/2 Active not recruiting
NCT04699123 2025-05-13
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
Yale University
Phase 2 Active not recruiting
NCT05215067 2025-03-12
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
Akeso
Phase 2 Active not recruiting
NCT04818333 2024-06-13
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Active not recruiting